Evaluation of ITGB1 expression as a predictor of the therapeutic effects of immune checkpoint inhibitors in gastric cancer
出版年份 2023 全文链接
标题
Evaluation of ITGB1 expression as a predictor of the therapeutic effects of immune checkpoint inhibitors in gastric cancer
作者
关键词
-
出版物
BMC GASTROENTEROLOGY
Volume 23, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-09-04
DOI
10.1186/s12876-023-02930-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer
- (2022) Ning Kang et al. BMC GASTROENTEROLOGY
- Identification and Validation of Immune Cells and Hub Genes in Gastric Cancer Microenvironment
- (2022) Huan Wang et al. DISEASE MARKERS
- AC010973.2 promotes cell proliferation and is one of six stemness-related genes that predict overall survival of renal clear cell carcinoma
- (2022) Yingqing Liu et al. Scientific Reports
- Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches
- (2022) Sangjoon Choi et al. Biomedicines
- ITGB1 as a prognostic biomarker correlated with immune suppression in gastric cancer
- (2022) Wenchao Gu et al. Cancer Medicine
- Identification of molecular patterns and prognostic models of epithelial–mesenchymal transition- and immune-combined index in the gastric cancer
- (2022) Xiuyuan Zhang et al. Frontiers in Pharmacology
- Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer
- (2022) Junquan Song et al. Frontiers in Immunology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrated Analysis of the Prognosis-Associated RNA-Binding Protein Genes and Candidate Drugs in Renal Papillary Cell Carcinoma
- (2021) Silin Jiang et al. Frontiers in Genetics
- Identification of novel autophagy-related lncRNAs associated with a poor prognosis of colon adenocarcinoma through bioinformatics analysis
- (2021) Dejun Wu et al. Scientific Reports
- Type I collagen promotes tumor progression of integrin β1 positive gastric cancer through a BCL9L/β-catenin signaling pathway
- (2021) Yalei Lv et al. Aging-US
- Integrin β1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells
- (2021) Joana Figueiredo et al. Gastric Cancer
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers
- (2021) Tiantian Wu et al. Frontiers in Immunology
- Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
- (2021) Yuang Wei et al. Frontiers in Genetics
- Advances in clinical immunotherapy for gastric cancer
- (2021) Kexin Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- ITGB1-DT/ARNTL2 axis may be a novel biomarker in lung adenocarcinoma: a bioinformatics analysis and experimental validation
- (2021) Bai-Quan Qiu et al. Cancer Cell International
- Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer
- (2021) H. Kim et al. Clinical & Translational Oncology
- SNAI1 is a prognostic biomarker and correlated with immune infiltrates in gastrointestinal cancers
- (2020) Jiaying Fang et al. Aging-US
- Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer
- (2020) Hongkai Zhuang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Ropivacaine inhibits the proliferation and migration of colorectal cancer cells through ITGB1
- (2020) Xiao Wang et al. Bioengineered
- First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
- (2020) Hyun Cheol Chung et al. Future Oncology
- Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion
- (2019) Yuanyuan Jiang et al. CANCER LETTERS
- Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy
- (2019) Jeffrey C. Thompson et al. LUNG CANCER
- Contextual determinants of TGFβ action in development, immunity and cancer
- (2018) Charles J. David et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- Prognostic role of tumor-infiltrating lymphocytes in gastric cancer
- (2018) Jung Soo Lee et al. MEDICINE
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- TGFΒ-induced transcription in cancer
- (2017) Gaia Cantelli et al. SEMINARS IN CANCER BIOLOGY
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
- (2016) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Interaction between Wnt/β-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancer (Review)
- (2016) CUNEN WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- TGF-β1-Induced Epithelial–Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells
- (2015) Joel Johansson et al. Frontiers in Oncology
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial–mesenchymal transition in gastrointestinal cancer
- (2013) Haoxuan Zheng et al. EUROPEAN JOURNAL OF CANCER
- Fas signaling promotes motility and metastasis through epithelial–mesenchymal transition in gastrointestinal cancer
- (2012) H X Zheng et al. ONCOGENE
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started